Online, part-time
Global Medicines Development MScDevelop scientific and leadership skills to navigate the complex challenges in global medicines development.
Key information
Study mode: |
100% online |
Duration: |
2 years, part time |
Next start date: |
September 2025 |
Application deadline: |
Date TBC |
Intakes: |
September 2025, January 2026 and May 2026 |
Tuition fees: |
£19,944* (funding options and instalments are available) |
These tuition fees may be subject to increases in subsequent years of study, in line with King's terms and conditions.
* Depending on your country of residence, you may also have to pay Goods and Services Tax (GST) in addition to your tuition fees. You can find further information on the King's Goods and Services tax page.
Programme overview
Transforming a molecule, cell, or gene into a life-changing medicine requires a multidisciplinary approach, substantial investment, and years of development. It also demands a deep understanding of the entire medicine lifecycle—from discovery to delivery.
With rising global healthcare needs, there is an increasing demand for professionals equipped with the skills to develop medicines that are safe, effective, and accessible. This MSc bridges critical skill gaps in the pharmaceutical industry, providing advanced training in the end-to-end development process.
Designed for professionals in the pharmaceutical or healthcare industries and motivated graduates aiming to enter these fields, this online programme equips students with a global perspective, blending expertise from leading academic researchers and industry professionals.
Grounded in the PharmaTrain curriculum, the programme explores advanced topics like clinical trial management, regulatory compliance, and commercialisation strategies. As a graduate, you will be ready to drive innovation in drug development and contribute to future medical breakthroughs.
Apply nowWho is this programme for?
- Professionals in the pharmaceutical or related industries seeking career progression.
- Healthcare practitioners transitioning into roles in medicines development, medical affairs or commercialisation.
- Graduates in medicine, pharmacy, or life sciences aiming to specialise in medicines development.
- Industry professionals seeking globally relevant and flexible training that will allow them to balance work, life and study commitments.
Why choose this online MSc?
Industry expertise
Learn directly from globally recognised experts who have pioneered the development of medicines, including vaccines, biopharmaceuticals, and cell and gene therapies.
Global prestige
King’s College London is a leading global university and the Centre for Pharmaceutical Medicine Research at King’s is a PharmaTrain Centre for Excellence, ensuring a rigorous, industry-relevant education.
Career advancement
This MSc offers a recognised pathway for professionals in medicines development and medical or commercial roles, paving the way for advanced leadership opportunities in the industry.
Future accreditation opportunities
Graduates of this MSc can apply for accreditation opportunities such as the Diploma in Pharmaceutical Medicine, further enhancing their credentials.
What you'll study
The Global Medicines Development MSc guides you through the key stages of a medicine’s lifecycle, from discovery and non-clinical testing to clinical development, licensing, regulations, safety, and commercialisation.
Key learning outcomes include:
- Planning and implementing effective medicines development and commercialisation strategies.
- Critically evaluating and adapting to evolving global regulatory requirements.
- Understanding advances in drug discovery and clinical development, and their alignment with global healthcare markets and patient access strategies.
- Enhancing leadership and negotiation skills to manage complex projects across the pharmaceutical industry.
Upon graduation, you will be prepared to take on leadership roles and contribute to strategic decision-making in the pharmaceutical sector.
Module overview
The MSc in Global Medicines Development has 11 modules, totaling 180 credits. All modules are compulsory. They are designed to be standalone whilst building a detailed exploration of medicines development as you proceed through the programme. This allows you to learn in line with your own professional priorities and goals.
Core modules:
The delivery of safe and effective medicines is central to this module. You will learn how the clinical development process is linked to a company’s strategy, ensuring medicines meet the needs of patients, healthcare professionals, policymakers, and regulators. Key topics include patient engagement, intellectual property, health technology assessment, and commercialisation. Through case studies and practical exercises, you will develop the skills to critically assess development strategies, craft patient-focused approaches, and design multidisciplinary plans that integrate compliance, market requirements, and patient access.
This module reviews the ethical principles and good practices underpinning the development and commercialisation of medicines, focusing on how the pharmaceutical industry should protect patients and the public. It explores key issues such as consent processes, regulatory frameworks, and pharmacoepidemiology. Through discussions and real-world cases, you will evaluate ethical dilemmas, explore robust patient involvement plans for multinational clinical programmes and assess risk-benefit evidence from clinical and non-clinical studies.
Suitable for both newcomers and experienced professionals, this module deepens your understanding of ethics, professionalism, and regulatory compliance in medicines development.
The foundational stages of drug development require a careful integration of theory and practice. You will explore the principles of chemistry, pharmacology, toxicology, and pharmaceutics, learning to design dosage forms and pharmaceutical processes tailored to clinical needs. Key topics include preclinical toxicology, pharmacokinetics, and regulatory requirements.
Through hands-on exercises, you will evaluate data supporting the progression of medicines into first-in-human trials, addressing challenges such as formulation, stability testing, and scale-up for clinical use. This module offers a comprehensive understanding of non-clinical development, vital for advancing innovative therapies.
Global regulatory frameworks guide the development, approval, and lifecycle management of medicines. You will study the interplay between science, public policy, and regulations, focusing on critical areas such as clinical trial authorisations, marketing authorisation, pharmacovigilance, and requirements for special populations.
Through interactive workshops, you will design regulatory strategies, prepare essential documentation, and tackle practical challenges, including risk minimisation and managing off-label medicines.
By the end of the module, you will have a comprehensive understanding of regulatory science and its role in ensuring medicines are safe, effective, and accessible.
Clinical trial design and management are pivotal to the successful development of new medicines. In this module, you will learn to develop clinical development plans, create robust trial protocols, and manage essential components such as investigator selection, vendor contracts, and data collection strategies.
Statistical methodologies, including power calculations and error analysis, are explored to ensure trial designs are scientifically sound and regulatory compliant.
Practical exercises and assessments will equip you with the skills needed to address real-world challenges, ensuring high-quality data generation and analysis throughout the trial process.
Ensuring drug safety throughout a medicine’s lifecycle is vital to protecting patients and maintaining public trust. This module examines the principles of pharmacovigilance and pharmacoepidemiology, covering risk assessment, adverse event monitoring, and safety management practices.
You will learn to create risk management plans, design systems for safety signal detection, and evaluate methodologies for generating reliable safety evidence.
Practical exercises will help you develop strategies to mitigate risks during clinical trials and post-marketing. By the end of the module, you will have a strong foundation in safety assessment and risk management essential for lifecycle management of medicines.
Managing clinical trials requires a balance of strategic oversight and practical expertise. This module equips you with the knowledge and tools to coordinate trials effectively, from single-site studies to large-scale, multinational projects.
Topics include site selection, patient recruitment, adverse event management, and ensuring quality across trial supplies. You will also learn to apply project tracking systems, manage data collection, and resolve challenges such as slow data flow or team dynamics.
By the end of this module, you will be prepared to lead complex clinical trial operations and maintain high standards of compliance and scientific integrity.
Medical Affairs professionals play a pivotal role in the development, commercialisation, and lifecycle management of medicines. You will learn how to execute the key functions of Medical Affairs practitioners, focusing on planning and leading initiatives such as medical education programmes and health technology assessments.
You will critically evaluate approaches to addressing drug development questions, considering factors like regulatory approval, stakeholder engagement, ethics, and corporate responsibility.
By the end of the module, you will have the skills and knowledge to lead strategic medical affairs projects that enhance the development and use of new medicines.
Advances in cell biology and regenerative medicine are revolutionising the development of innovative therapies. You will engage in an in-depth study of cutting-edge research and clinical applications in areas such as stem cell biology and cell-based therapeutics.
You will assess the safety and risks of advanced therapies, exploring their potential to address degenerative disorders and other unmet medical needs. You will learn to develop pharmaceutical plans for advanced therapies, equipping you with the skills to translate scientific discoveries into effective clinical solutions.
Bringing new medicines to market requires a deep understanding of the scientific, financial, and operational factors that drive commercial success. This module explores the key elements of business planning, market positioning, and investor relations, emphasising strategies that integrate manufacturing and market access considerations.
Through practical exercises and case studies, you will critically evaluate commercialisation strategies, create business plans, and assess factors influencing market penetration and profitability.
By the end of the module, you will be equipped with the skills to navigate the complexities of commercialising innovative therapies and achieving sustainable success.
This capstone project brings together all the knowledge and skills developed throughout the programme, challenging you to create a comprehensive development plan for a new pharmaceutical product.
You will evaluate strategic business decisions, navigate complex regulatory frameworks, and craft proposals that appeal to potential investors or collaborators. Practical application is emphasised, enabling you to integrate entrepreneurial insights into the development and commercialisation of innovative therapies.
This module prepares you to tackle real-world challenges in medicines development, equipping you with the expertise needed to lead and succeed in the pharmaceutical industry.
Meet the Programme Director
Professor Stuart Jones
Director of the Centre for Pharmaceutical Medicine Research, Programme Director, online Global Medicines Development MSc
Stuart holds a Chair in Pharmaceutical Medicine at King’s College London. He leads research focused on developing innovative medicines and medical devices. With experience working in the pharmaceutical industry and over 17 years of experience in academia, he specialises in pharmaceutical dermatology. His work drives advancements in diagnostics and therapeutics for the management of skin disease.
How you’re assessed
Assessments are designed to test your knowledge, understanding, and critical awareness of the topics discussed during the programme. They also evaluate your ability to analyse and apply specialist knowledge to practice. While these may vary between modules, they are likely to include one or more of the following:
Exams
Exams
Written assignments
Written assignments
Oral presentations
Oral presentations
A final capstone project
A final capstone project
Entry requirements
- A medical degree (MBBS or equivalent) or a 2:1 undergraduate degree in a relevant subject area (pharmacy, pharmacology, biology, biochemistry, chemistry or related), or overseas equivalent.
- If you’ve completed the Medical Affairs in Medicines Development CPD programme, you’ll need to state this in your application to receive accreditation of prior learning (APL).
Your application will also be considered if you meet the following requirements:
- A 2:2 honours degree in a relevant subject area (medicine, pharmacy, pharmacology, biology, biochemistry, chemistry or related), or overseas equivalent and professional experience in the pharmaceutical or other related industries.
- A 2:2 honours degree or above in a non-relevant subject area, or overseas equivalent and professional experience in the pharmaceutical or other related industries.
- If you’ve completed the Medical Affairs in Medicines Development CPD programme, you’ll need to state this in your application to receive accreditation of prior learning (APL).
English language band: D
To study at King's, it is essential that you can communicate in English effectively in an academic environment. You are usually required to provide certification of your competence in English before starting your studies.
Nationals of majority English speaking countries (as defined by the UKVI) who have permanently resided in this country are not usually required to complete an additional English language test. This is also the case for applicants who have successfully completed:
- An undergraduate degree (at least three years duration) within five years of the course start date.
- A postgraduate taught degree (at least one year) within five years of the course start date.
- A PhD in a majority English-speaking country (as defined by the UKVI) within five years of the course start date.
For information on our English language requirements and whether you need to complete an English language test, please see our English Language requirements page.
Depending on your previous qualifications, you may need to submit a personal statement and a reference letter as part of your application.
You’ll need to submit a copy (or copies) of your official academic transcript(s), showing the subjects studied and marks obtained. If you’ve already completed your degree, copies of your official degree certificate will also be required.
Applicants with academic documents issued in a language other than English, will need to submit both the original and official translation of their documents. You’ll need to submit your CV as part of your application to highlight your experience.
Not sure if you meet the requirements, or if the course is right for you? Speak to our team to get tailored support:
Discuss my optionsCareer options in Global Medicines Development
This MSc bridges critical skills gaps in the pharmaceutical industry, preparing you for leadership roles in an evolving healthcare landscape. The rising prevalence of chronic diseases and the demand for equitable access to innovative therapies have created significant opportunities for professionals in drug development. This programme provides the strategic, technical, and regulatory expertise needed to thrive in global pharmaceutical markets.
You'll gain advanced competencies in areas such as regulatory compliance, clinical trial management, pharmacovigilance, health economics, and commercialisation strategies. By combining theoretical knowledge with practical problem-solving exercises, you'll be equipped to address challenges across the entire lifecycle of medicines—from discovery to market access. You'll take a multidisciplinary approach, drawing on insights from drug discovery, advanced therapies, and health technology assessment.
Affiliated with the International Federation of Associations of Pharmaceutical Physicians (IFAPP), the MSc provides cutting-edge industry insights, while fostering transferable skills in communication, decision-making, and leadership—key for success in competitive markets.
As a graduate, you’ll be prepared to pursue impactful careers in fields such as:
- Drug development
- Regulatory affairs
- Clinical trials
- Medical affairs
- Pharmacovigilance
- Health economics
- Product commercialisation
- Global strategic management
Whether you’re advancing within your current organisation or exploring new opportunities, this MSc equips you to contribute meaningfully to global healthcare innovation. With a thorough understanding of the pharmaceutical landscape, you will be ready to drive the development of life-changing medicines that meet patient needs worldwide.
To learn more about potential job roles, visit the Association of the British Pharmaceutical Industry (ABPI) website.
Ready to join us?
Discover more
You have the potential. We’ll help you unleash it. Take charge of your future today.
Questions about our courses, studying online or the application process? Our expert Enrolment Advisors are on-hand to help. Simply fill in the form below, and they’ll get in touch with you shortly.
Fields with a '*' are mandatory.